Signal Transduction and Targeted Therapy

ISSN: 2095-9907• JCR: SIGNAL TRANSDUCT TARSpringer NatureUnited Kingdom
Visit Journal Homepage
52.7
2025 Impact Factor
52.2
5-Year Impact Factor
Q1
JCR Quartile
B1
CAS Block

Signal Transduction and Targeted Therapy impact factor and JCR quartile

The 2025 impact factor for Signal Transduction and Targeted Therapy is 52.7. The 5-year impact factor is 52.2. The journal is listed as JCR Q1 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Signal Transduction and Targeted Therapy impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Signal Transduction and Targeted Therapy impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
2,691
H-Index
262
Open Access
Yes
APC
$2,373 USD
Subject Areas
Infectious DiseasesInfectious DiseasesMolecular BiologyOncologyImmunology

Article Volume

2021
445
2022
402
2023
467
2024
371
2025
427
2026
114
Back to Search